Assays for determination of HIV resistance to antiviral drugs

被引:3
作者
Baldanti, F [1 ]
Paolucci, S [1 ]
Dossena, L [1 ]
Gerna, G [1 ]
机构
[1] IRCCS, Serv Virol, Policlin San Matteo, I-27100 Pavia, Italy
关键词
D O I
10.2174/1389200043335496
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to antiretroviral drugs is one of the major pitfalls of combined treatment of HIV infection. Thus timely identification of drug resistant HIV strains and precise evaluation of the level of resistance to the different antiretroviral drugs are crucial in the management of treated patients. phenotypic determination of antiretroviral drug resistance evaluates the ability of an HIV strain to replicate in the presence of drug(S). Thus. this assay (either conventional or recombinant) provides a direct estimate of drug susceptibility. However, it is relatively difficult to perform and requires dedicated facilities. Thus, its use is still restricted. Genotypic determination of drug resistance is based upon detection of specific mutations in HIV genes encoding target enzymes or receptors. The assay provides an indirect evidence of drug Susceptibility. However. it is easy to perform and does not require dedicated facilities. Thus. it is widely utilized in clinical practice. Its major limitation concerns the complexity of results interpretation which still awaits a general consensus.
引用
收藏
页码:317 / 319
页数:3
相关论文
共 33 条
[2]   Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay [J].
Boucher, CAB ;
Keulen, W ;
vanBommel, T ;
Nijhuis, M ;
DeJong, D ;
DeJong, MD ;
Schipper, P ;
Back, NKT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2404-2409
[3]   Social support and quality of life over time among adults living with HIV in the HAART era [J].
Burgoyne, R ;
Renwick, R .
SOCIAL SCIENCE & MEDICINE, 2004, 58 (07) :1353-1366
[4]   Nonnucleoside reverse transcriptase inhibitor resistance [J].
Deeks, SG .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S25-S33
[5]   Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations [J].
Demeter, L ;
Haubrich, R .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S3-S9
[6]  
Günthard HF, 1998, J VIROL, V72, P2422
[7]   Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses [J].
Gzy, J ;
Bolesta, E ;
Wierzbicki, A ;
Kmieciak, D ;
Naito, T ;
Honda, M ;
Komuro, K ;
Kaneko, Y ;
Kozbor, D .
VIROLOGY, 2004, 318 (02) :493-506
[8]   Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4+ cell clone 1-10 (MAGIC-5) [J].
Hachiya, A ;
Aizawa-Matsuoka, S ;
Tanaka, M ;
Takahashi, Y ;
Ida, S ;
Gatanaga, H ;
Hirabayashi, Y ;
Kojima, A ;
Tatsumi, M ;
Oka, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :495-501
[9]   Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy [J].
Hance, AJ ;
Lemiale, V ;
Izopet, J ;
Lecossier, D ;
Joly, V ;
Massip, P ;
Mammano, F ;
Descamps, D ;
Brun-Vézinet, F ;
Clavel, F .
JOURNAL OF VIROLOGY, 2001, 75 (14) :6410-6417
[10]   Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. -: J Antimicrob Chemother 1998; 42:269-270 [J].
Vahaboglu, H ;
Saribas, S ;
Akbal, H ;
Ozturk, R ;
Yucel, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :269-270